One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation

References

• Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11�14 weeks of gestation: an observational study. Lancet 2001; 358: 1665�7
   Google Scholar
• Cuckle H. Time for total shift to first-trimester screening for Down�s syndrome. Lancet 2001;358:1658�9
   Web of Science ®Google Scholar
• Hyett JA, Perdu M, Sharland GK, Snijders RJM, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10�14 weeks of gestation: population based cohort study. Br Med J 1999;318: 81�5
   Google Scholar
• Souka AP, Snijders RJM, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10�14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11: 391�400
   Google Scholar
• Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increasednuchal translucencyin the first trimester. Ultrasound Obstet Gynecol 2001;18:9�17
   Google Scholar
• Snijders RJM, Nicolaides KH, eds. Assessment of risks. In UltrasoundMarkers for Fetal Chromosomal Defects. Carnforth, UK: Parthenon Publishing 1996;63�120
   Google Scholar
• Hecht CA, Hook EB. The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn 1994;14: 729�38
   Web of Science ®Google Scholar
• Snijders RJM, Sebire NJ, Cuckle H, NicolaidesKH. Maternal age and gestational age-specific risks for chromosomal defects. Fetal Diagn Ther 1995;10:356�67
   Web of Science ®Google Scholar
• SnijdersRJM, Sundberg K, HolzgreveW, Henry G,Nicolaides KH. Maternal age and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13: 167�70
   Google Scholar
• Halliday JL, Watson LF, Lumley J, Danks DM, Sheffield LJ. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age froma uniquely defined population. Prena Diagn 1995;15:455�65
   Google Scholar
• Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142�45
   Google Scholar
• Langdon Down J. Observations on an ethnic classification of idiots. Clin Lectures and Reports, London Hospital 1866; 3:259�62
   Google Scholar
• Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304: 867�89
   Google Scholar
• Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJM, Nicolaides KH. The implementation of firsttrimester scanning at 10�13 weeks� gestationand the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995;5: 20�5
   Google Scholar
• Szabo J, Gellen J, Szemere G. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995;5: 161�3
   Google Scholar
• Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucencyas a marker for fetal chromosomaldefects. N Engl J Med 1997;337:1654�8
   Web of Science ®Google Scholar
• Hafner E, Schuchter K, Liebhart E, Philipp K. Results of routine fetal nuchal translucency measurement at 10�13 weeks in 4,233 unselected pregnant women. Prenat Diagn a1998;18:29�34
   Web of Science ®Google Scholar
• Pajkrt E, van Lith JMM, Mol BWJ, Bleker OP, Bilardo CM. Screening for Down�s syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 1998;12:163�9
   Web of Science ®Google Scholar
• Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10�14 weeks of gestation. Lancet 1998;351: 343�6
   Google Scholar
• Economides DL, Whitlow BJ, Kadir R, Lazanakis M, Verdin SM. First trimester sonographic detection of chromosomal abnormalities in an unselected population. Br J Obstet Gynaecol 1998;105:58�62
   Google Scholar
• Schwarzler P, CarvalhoJS, Senat MV,Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10�14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999; 106: 1029�34
   Google Scholar
• Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Prenat Diagn 1998;18:133�7
   Web of Science ®Google Scholar
• Zoppi MA, Ibba RM, Floris M, Monni G. Fetal nuchal translucency screening in 12 495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001;18:649�51
   Web of Science ®Google Scholar
• Gasiorek-Wiens A, Tercanli S, Kozlowski P, et al. Screening for trisomy21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 2001;18: 645�8
   Google Scholar
• Brizot ML, Carvalho MHB, Liao AW, et al. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population. Ultrasound Obstet Gynecol 2001;18:652�5
   Web of Science ®Google Scholar
• Audibert F, Dommergues M, Benattar C, et al. Screening for Down syndrome using first-trimester ultrasound and secondtrimester maternal serum markers in a low-risk population: a prospective longitudinal study. Ultrasound Obstet Gynecol 2001;18:26�31
   Web of Science ®Google Scholar
• Wayda K, KereszturiA, Orvos H, et al. Four years experienceof first-trimester nuchal translucency screening for fetal aneuploidieswith increasing regional availability. Acta Obstet Gynecol Scand 2001;80:1104�9
   Web of Science ®Google Scholar
• NicolaidesKH, SebireNJ, SnijdersRJM. Nuchal translucency and chromosomal defects. In Nicolaides KH, ed. The 11�14-week Scan: The Diagnosis of Fetal Abnormalities Carnforth, UK, Parthenon Publishing, 1999:3�65
   Google Scholar
• Sherrod C, Sebire NJ, SoaresW, Snijders RJ, Nicolaides KH. Prenatal diagnosis of trisomy 18 at the 10�14-week ultrasound scan. Ultrasound Obstet Gynecol 1997;10: 387�90
   Google Scholar
• Snijders RJM, Sebire NJ, Nayar R, Souka A, Nicolaides KH. Increased nuchal translucency in trisomy 13 fetuses at 10�14 weeks of gestation.Am J Med Genet 1999;86: 205�7
   Google Scholar
• Sebire NJ, Snijders RJ, Brown R, Southall T, Nicolaides KH. Detection of sex chromosome abnormalities by nuchal translucency screening at 10�14 weeks. Prenat Diagn 1998;18: 581�4
   Google Scholar
• Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH. Early prenatal diagnosis of triploidy. Am J Obstet Gynecol 1997;176:550�4
   Google Scholar
• Braithwaite JM, Kadir RA, Pepera TA, Morris RW, Thompson PJ, Economides DL. Nuchal translucencymeasurement: training of potential examiners. Ultrasound Obstet Gynecol 1996;8:192�5
   Web of Science ®Google Scholar
• Pandya PP,Altman D, BrizotML, PettersenH, NicolaidesKH. Repeatability of measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;5:334�7
   Web of Science ®Google Scholar
• Whitlow BJ, Chatzipapas IK, Economides DL. The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynaecol 1998;105:872�6
   Google Scholar
• Braithwaite JM, Morris RW, Economides DL. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 1996;103:1201�4
   Google Scholar
• Schaefer M, Laurichesse-Delmas H, Ville Y. The effect of nuchal cord on nuchal translucency measurement at 10�14 weeks. Ultrasound Obstet Gynecol 1998;11:271�3
   Web of Science ®Google Scholar
• Kornman LH, Morssink LP, Beekhuis JR, DeWolf BTHM, Heringa MP, Mantingh A. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice. Prenat Diagn 1996;16:797�805
   Web of Science ®Google Scholar
• Bower S, Chitty L, Bewley S, Roberts L, Clark T, Fisk NM, Maxwell D, Rodeck CH. First trimester nuchal translucency screening of the general population: data from three centres [abstract]. Presented at the 27th British Congress of Obstetrics and Gynaecology, Dublin, Royal College of Obstetrics and Gynaecology, 1995
   Google Scholar
• Roberts LJ, Bewley S, Mackinson AM, Rodeck CH. First trimester fetal nuchal translucency: problems with screening the general population. 1. Br J Obstet Gynaecol 1995;102:381�5
   Google Scholar
• Monni G, ZoppiMA, Ibba RM, FlorisM. Results of measurement of nuchal translucency before and after training. Lancet 1997;350:1631
   PubMedGoogle Scholar
• Cuckle HS, van Lith JM.Appropriatebiochemicalparameters in first-trimester screening for Down syndrome. Prenat Diagn 1999;19:505�12
   Google Scholar
• Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10�14 weeks using fetal nuchal translucency, maternal serum free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13: 231�7
   Google Scholar
• Krantz DA, Larsen JW, Buchanan PD, Macri JN. First trimester Down syndrome screening: free b-human chorionic gonadotropin and pregnancy associated plasma protein A. Am J Obstet Gynecol 1996;174: 612�16
   Web of Science ®Google Scholar
• Wald NJ, George L, Smith D, Densem JW, Petterson K, on behalf of the International Prenatal Screening Research Group. Serum screening for Down�s syndrome between 8 and 14weeks of pregnancy.Br J ObstetGynaecol1996;104: 407�12
   Google Scholar
• Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM. Screening for Down�s syndrome: changes in marker levels and detection rates between first and second trimester. Br J Obstet Gynaecol 1997;104:811�17
   Google Scholar
• HaddowJE, Palomaki GE, KnightGJ,Williams J,Miller WA, Johnson A. Screening of maternal serum for fetal Down�s syndrome in the first trimester. N Engl J Med 1998;338:955�61
   Google Scholar
• Wheeler DM, Sinosich MJ. Prenatal screening in the first trimester of pregnancy. Prenat Diagn 1998;18:537�43
   Web of Science ®Google Scholar
• de Graaf IM, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, Van Lith JM. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn 1999;19:458�62
   Google Scholar
• Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN. First-trimester screening for aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 1997;10: 381�6
   Google Scholar
• Tsukerman GL, Gusina NB, Cuckle HS. Maternal serum screening for Down syndrome in the first trimester:experience from Belarus. Prenat Diagn 1999;19:499�504
   Google Scholar
• Brizot ML, Snijders RJM, Bersinger NA, Kuhn P, Nicolaides KH.Maternal serumpregnancy associatedplacental proteinA and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol 1994; 84:918�22
   Google Scholar
• Brizot ML, Snijders RJM, Butler J, Bersinger NA, Nicolaides KH. Maternal serum hCG and fetal nuchal translucency thickness for the predictionof fetal trisomiesin the first trimester of pregnancy. Br J Obstet Gynaecol 1995;102:1227�32
   Google Scholar
• De Biasio P, SiccardiM, Volpe G, FamularoL, Santi P, Canini S. First trimester screening for Down�s syndrome using nuchal translucency measurement with free b-hCG and PAPP-A between 10 and 13 weeks of pregnancy: the combined test. Prenat Diagn 1999;19:360�3
   Web of Science ®Google Scholar
• Tul N, Spencer K, Noble P, Chan C, Nicolaides KH. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free betahCG and PAPP-A at 10�14 weeks of gestation. Prenat Diagn 1999;19: 1035�42
   Google Scholar
• Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH. Screening for trisomy 13 by fetal nuchal translucency and maternal serumfree betahCG and PAPP-A at 10–14 weeks of gestation. Prenat Diagn 2000;in press
   Google Scholar
• Spencer K, Tul N, Nicolaides KH. Maternal serum free beta hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 2000;in press
   Google Scholar
• Spencer K, Liao A, Skentou H, Cicero S, Nicolaides KH. Screening for triploidy by fetal nuchal translucency and maternal serum free b-hCG and PAPP-A at 10�14 weeks of gestation. Prenat Diagn 2000;in press
   Google Scholar
• Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down�s syndromebased on tests performedduring the first and second trimesters. N Engl J Med 1999;341:461�7
   Google Scholar
• Copel J, Bahado-Singh RO. Prenatal screening for Down�s syndrome � a search for the family�s values. N Engl J Med 1999;341:521�2
   Web of Science ®Google Scholar
• Kadir RA, Economides DL. The effect of nuchal translucency measurement on second trimester biochemical screening for Down�s syndrome. Ultrasound Obstet Gynecol 1997;9:244�7
   Web of Science ®Google Scholar
• Thilaganathan B, Slack A, Wathen NC. Effect of firsttrimester nuchal translucency on second-trimester maternal serumbiochemical screeningfor Down�s syndrome. Ultrasound Obstet Gynecol 1997;10:261�4
   Google Scholar
• Schuchter K, Hafner E, Stangl G, et al. Sequential screening for trisomy21 by nuchal translucencymeasurementin the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.Ultrasound Obstet Gynecol 2001;18:23�5
   Web of Science ®Google Scholar